David White and Lauren Ahearn interview colleagues Zach Kribs and Rachel Meyer about HRSA's OPTN Modernization Initiative and H.R. 2544. Contact HRSA about the OPTN Modernization Initiative here- https://www.hrsa.gov/optn-modernization/contact

With the start of summer comes the start of the busy policy season. Tod Ibrahim, David White, and Lauren Ahearn discuss the recent SCOTUS decision on affirmative action, the CY2024 ESRD PPS QIP proposed rule, and ASN's upcoming Transplant Advocacy Day.

In this Regulatory and Legislative update David White and Tod Ibrahim discuss Medicaid redetermination, concurrent dialysis and hospice, and the case of Braidwood Management vs. Becerra.

David White speaks with ASN President Michelle A. Josephson, MD, FASN, and ASN Strategic Policy Advisor to the Executive Vice President Rachel Meyer about changes within HRSA, big-picture issues within transplant nephrology, and more.

In this episode, Tod and David discuss recent updates from within the Department of Health and Human Services, including changes in the OPTN, the back-and-forth between the FDA and CMS on the accelerated approval of drugs, and more.

In this episode, David speaks with Zach Kribs, ASN Manager of Congressional Affairs, on Kidney Community Advocacy Day, ASN's goals for Hill Day 2023, Congressional priorities in 2023, the debt ceiling, and more.

In this episode, Tod and David discuss ASN's responses to recent regulatory proposals, including technical changes in the Medicare Advantage program, the 2728 form, and the USPSTF.

In this episode, Tod and David discuss President Biden's State of the Union address and its implications for the kidney community through 2024.

In this episode, Tod and David discuss today's political landscape, the debt ceiling, priorities and considerations for the kidney community in 2023, and more.

In this episode, ASN Manager of Congressional Affairs, Zachary Kribs, joins Tod and David in discussing what to expect from Congress going into 2023.